Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
9,051,029
-
Shares change
-
+9,051,029
-
Total reported value, excl. options
-
$107,615,000
-
Value change
-
+$107,615,000
-
Number of buys
-
28
-
Price
-
$11.89
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q3 2020
28 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q3 2020.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,051,029 shares
of 153,881,229 outstanding shares and own 5.88% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,708,507 shares), Johnson & Johnson Innovation - JJDC, Inc. (662,676 shares), Nantahala Capital Management, LLC (415,189 shares), Ikarian Capital, LLC (274,277 shares), BAILLIE GIFFORD & CO (181,626 shares), BlackRock Inc. (134,060 shares), Artal Group S.A. (129,335 shares), ACADIAN ASSET MANAGEMENT LLC (107,167 shares), VANGUARD GROUP INC (93,803 shares), and DAFNA Capital Management LLC (67,577 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.